Abstract
The detection of epithelial cells in bone marrow, blood or lymph nodes indicates a disseminatory potential of solid tumours. 225 patients with squamous cell carcinoma of the oesophagus were prospectively studied. Prior to any therapy, cytokeratin-positive (CK) cells in bone marrow were immunocytochemically detected in 75 patients with the monoclonal anti-epithelial-cell antibody A45-B/B3 and correlated with established histopathologic and patient-specific prognosis factors. The prognosis factors were assessed by multivariate analysis. Twenty-nine of 75 (38.7%) patients with oesophageal cancer showed CK-positive cells in bone marrow. The analyses of the mean and median overall survival time showed a significant difference between patients with and without epithelial cells in bone marrow (P< 0.001). Multivariate analysis in the total patient population and in patients with curative resection of the primary tumour confirmed the curative resection rate and the bone marrow status as the strongest independent prognostic factors, besides the T-category. The detection of epithelial cells in bone marrow of oesophageal cancer patients is a substantial prognostic factor proved by multivariate analysis and is helpful for exact preoperative staging, as well as monitoring of neoadjuvant therapy. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ajani JA (1996) Therapy of carcinoma of the oesophagus: either attempt it not or succeed. Eur J Cancer 31A: 790–793
Anderson LL and Lad TE (1982) Autopsy findings in squamous cell carcinoma of the oesophagus. Cancer 50: 1587–1590
Bolton JS, Ochsner JL and Abdoh AA (1994) Surgical management of oesophageal cancer. A decade of change. Ann Surg 219: 475–480
Brookmeyer R and Crowley J (1982) A confidence interval for the median survival time. Biometrics 38: 29–41
Diel IJ and Kaufmann M (1996) Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88: 1652–1656
Dittler HJ and Siewert JR (1993) Role of endoskopic ultrasonography in oesophageal cancer. Endoscopy 15: 156–161
Fink U, Stein HJ, Wilke HJ and Siewert JR (1995) Multimodal treatment for squamous cell oesophageal cancer. World J Surg 19: 198–204
Funke I and Schraut W (1998) Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557–566
Glickman JN, Torres C, Wang HH, Turner JR, Shahsafael A, Richards WG, Sugarbaker DJ and Odze RD (1999) The prognostic significance of lymph node micrometastasis in patients with oesophageal carcinoma. Cancer 15: 769–778
Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW and Schlldberg FW (1995) Individual development and uPa- receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1: 1035–1039
Herskovic A, Martz K and Al-Sarraf M (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med 326: 1593–1598
Izbicki JR, Hosch SB, Pichimeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE and Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected oesophageal cancer. N Engl J Med 337: 1188–1194
Johnson PWM, Burchill SA and Selby PJ (1995) The molecular detection of circulating tumour cells. Br J Cancer 72: 268–273
Kaplan EL and Meyer P (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53: 457–481
Law SYK, Fok M and Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83: 107–111
Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685–689
Mandard AM, Chasle J, Marnay J, Villedleu B, Blanco C and Roussel A (1981) Autopsy findings in 111 cases of oesophageal cancer. Cancer 48: 329–335
Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD and Seeger RC (1991) Prognostic value of imunocytological detection of bone marrow metastases in neuroblastoma. N Engl J Med 324: 219–226
Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H and Siewert JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from oesophageal squamous cel carcinoma. Cancer 83: 858–866
Pantel K, Schllmok G, Braun S, Kutter D, Schaller G, Funke I, Izbicki JR and Riethmüller G (1993) Differential expression of proliferation-associated molecules in individual metastatic carcinoma cells. J Natl Cancer Inst 85: 1419–1425
O’Sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, Walsh T, Collins JK and Shanahan F (1999) Micrometastases in oesophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 116: 543–548
Riethmüller G and Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic cancers. Curr Opin Immunol 3: 647–655
Siewert JR and Roder JD (1992) Lymphadenectomy in oesophageal cancer surgery. Diseases of the Oesophagus 5: 91–97
Siewert JR, Stein HJ and Fink U (1996) Multimodality therapy for oesophageal cancer. The Oncologist 1: 210–218
Thorban S, Roder JD, Pantel K and Siewert JR (1996) Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am J Surg 172: 297–298
Waish TN, Noonan N, Hollywood D, Kelly A, Keeling N and Henessy TPJ (1996) A comparison of multimodal treatment and surgery for oesophageal adenocarcinoma. N Engl J Med 335: 462–467
Wittekind CH and Wagner G (1997). UICC: TNM-Klassifikation maligner Tumoren, 5, Auflage, Springer-Verlag: Berlin, Heidelberg: New York
Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA and Duhayionsod FG (1993) Survival of patients with carcinoma of the oesophagus treated with combined modality therapy. J Thorac Cardvasc Surg 105: 749–755
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Thorban, S., Rosenberg, R., Busch, R. et al. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 83, 35–39 (2000). https://doi.org/10.1054/bjoc.2000.1199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1199